Experimental drug shows encouraging results against stomach


AFP - An experimental drug by US pharmaceutical giant Pfeizer reduces tumor growth and doubled the life expectancy in a test group of patients suffering a certain type of stomach cancer, according to research released at the annual American Society of Clinical Oncology conference.

Read more...